Report

Electric Mobility Paradigm Shift: Capturing the OpportunitiesTERI & YES Bank launched a report on the opportunities in revolutionizing the transport sector with EVs

Read more

Policy Brief

Measures to control air pollution in urban centres of India TERI recommends a nationwide clean air mission framework

Read more

Magazine

Energy Future | Jan-March 2018Cover story on how electric vehicles can resolve India's urban transport planning challenges

Read more

Publications

Thermal gasifiers to the rescue of MSME energy needs

Article
| May 21, 2018

Biomass gasifiers are a clean and cost-effective renewable energy source for the MSME sector in India

Can the technology behind Bitcoin aid transition to renewable energy?

Article
| May 18, 2018

In the transition to renewable energy, blockchain technology can enable decentralised energy distribution, monitoring and trading

GOBAR-DHAN - Re-emphasizing India's traditional practices

Article
| May 10, 2018

Biogas is an easy solution to wet waste, but a sustainable model requires govt subsidy support

Novel Targets and Advancements 18 in Drug Discovery: The Case of HIV-AIDS

Research Paper
| May 9, 2018

Since the very first report of acquired immune deficiency syndrome (AIDS) in the early 1980s in the United States, a number of advancements have taken place both in the structural and functional aspects of the human immunodeficiency virus (HIV) life cycle as well as anti-HIV drug design. While new drugs have come to the market and combination therapies have increased life expectancy, resistance and viral mutations have mandated introduction of new drugs in the market. Apart from two main classes of HIV inhibitors (reverse transcriptase and

Fungi: An Amazing and Hidden Source of Antimycobacterial compounds ​

Research Paper
| May 9, 2018

Tuberculosis is an endemic disease of the poverty ridden, undernourished and over populated countries of the world. It is also a systemic disease that is extremely dependent on the physiology of the system it invades and thus varies signifi cantly from person to person. New developments in the treatment of this d isease have rarely percolated down to the larger sections of the under privileged in our societies. The need for highly active, long acting, yet less expensive drugs against Multi-Drug Resistant (MDR)

​The Pharmacological Potential of Nonribosomal Peptides from Marine Sponge and Tunicates.

Research Paper
| May 9, 2018

Marine environments are largely unexplored and can be a source of new molecules for the treatment of many diseases such as malaria, cancer, tuberculosis, HIV etc. The Marine environment is one of the untapped bioresource of getting pharmacologically active nonribosomal peptides (NRPs). Bioprospecting of marine microbes have achieved many remarkable milestones in pharmaceutics.

​Isolation, characterization of endophytic fungi of Mimusops elengi (Bakul).​

Research Paper
| May 9, 2018

Fresh bark pieces of Mimusops elengiLinn. were used for the isolation of fungal endophytes using standard methods. Mimusops elengi is a small to a large evergreen medicinal plant found all over the different parts of India. Seventy one endophytic fungi belonging to ascomycetes (11.27%), coelomycetes (39.44%) and hyphomycetes (49.29%) were isolated from 200 segments of Mimusops elengi collected from University campus in SagarDistrict, Madhya Pradesh, India.

​Novel Anticancer Compounds from Endophytic Fungi

Research Paper
| May 9, 2018

​The search for natural bioactive metabolites having potential anticancer property dates back to the Ebers papyrus written in 1550 BC. Natural products from medicinal plants and microorganisms are the most consistent and productive source for the “first-in-class” drugs. After two decades of research, a great deal of interest has been generated by discovery of remarkable pharmacological agents from endophytic fungi residing asymptomatically within plant tissues.​

​Marine Fungi: A Source of Potential Anticancer Compounds

Research Paper
| May 9, 2018

Metabolites from marine fungi have hogged the limelight in drug discovery because of their promise as therapeutic agents. A number ofmetabolites related tomarine fungi have been discovered from various sources which are known to possess a range of activities as antibacterial, antiviral and anticancer agents. Although, over a thousand marine fungi based metabolites have already been reported, none of them have reached the market yet which could partly be related to non-comprehensive screening approaches and lack of sustained lead optimization.